Skip to content
2000
Volume 15, Issue 4
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Successful normalization of blood glucose in patients transplanted with pancreatic islets isolated from cadaveric donors established the proof-of-concept that Type 1 Diabetes Mellitus is a curable disease. Nonetheless, major caveats to the widespread use of this cell therapy approach have been the shortage of islets combined with the low viability and functional rates subsequent to transplantation. Gene therapy targeted to enhance survival and performance prior to transplantation could offer a feasible approach to circumvent these issues and sustain a durable functional β-cell mass in vivo. However, efficient and safe delivery of nucleic acids to intact islet remains a challenging task. Here we describe a simple and easy-to-use lentiviral transduction protocol that allows the transduction of approximately 80 % of mouse and human islet cells while preserving islet architecture, metabolic function and glucose-dependent stimulation of insulin secretion. Our protocol will facilitate to fully determine the potential of gene expression modulation of therapeutically promising targets in entire pancreatic islets for xenotransplantation purposes.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/1566523215666150630121557
2015-08-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/1566523215666150630121557
Loading

  • Article Type:
    Research Article
Keyword(s): Diabetes Mellitus; Gene transfer; Infection; Lentivirus; Pancreatic islet; Transduction
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test